A phase 2 study of HQK-1001, an oral fetal haemoglobin inducer, in β-thalassaemia intermedia

Benzer Materyaller

• A randomized Phase I/II Trial of HQK-1001, an oral fetal globin gene inducer, in β–thalassaemia intermedia and HbE/β–thalassaemia
  Yazar:: Fucharoen, Suthat, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• A phase 2 trial of HQK-1001 in HbE-β thalassemia demonstrates HbF induction and reduced anemia
  Yazar:: Patthamalai, Poramin, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• Thalassaemia Intermedia: an Update
  Yazar:: Taher, Ali T., ve diğerleri
  Baskı/Yayın Bilgisi: (2009)
• Endocrine and Bone Complications in β-Thalassemia Intermedia: Current Understanding and Treatment
  Yazar:: Inati, Adlette, ve diğerleri
  Baskı/Yayın Bilgisi: (2015)
• A Phase 1/2 Trial of HQK-1001, an Oral Fetal Globin Inducer, in Sickle Cell Disease
  Yazar:: Kutlar, Abdullah, ve diğerleri
  Baskı/Yayın Bilgisi: (2012)